PMA P100024S009

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S009
Product code
NYQ
Decision date
2016-04-12
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
Changes to the DNA propagation and purification processes.

Current openFDA PMA Record#

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S009
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2016-04-12
Decision code
OK30
Date received
2016-03-16
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Changes to the DNA propagation and purification processes.